Louis P. Lacasse serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Louis P. Lacasse has executed 3 insider transactions totaling $1.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2013 involved transacting 12,537 shares valued at $137.9K.
Louis P. Lacasse currently holds 685,937 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis P. Lacasse has been a net buyer of CNAT stock. They have purchased $1.4M and sold $0 worth of shares.
Louis P. Lacasse's most recent insider trade was on Jul 30, 2013, when they sold 12,537 shares at $11.00 per share.
Get notified when new Form 4 filings are submitted
| $11.00 |
| Discretionary |
| Jul 30, 2013 | CNAT | $0 | Conversion | 673,400 | $N/A | Discretionary |